Aterian director receives 25,555 restricted shares
Aterian, Inc. director equity grant reported Aterian, Inc. director Susan E. Lattmann reported receiving 25,555 shares of common stock on 01/23/2026 at a stated price of $0 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aterian, Inc. director equity grant reported
Aterian, Inc. director Susan E. Lattmann reported receiving 25,555 shares of common stock on 01/23/2026 at a stated price of $0 per share. These shares are restricted stock granted under Aterian’s 2018 Equity Incentive Plan and are subject to vesting. The award was provided in lieu of cash compensation for her service on the Board of Directors. Following this grant, she beneficially owns 162,465 shares of Aterian common stock in direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 25,555 | $0.00 | $0.00 |
Footnotes (2)
- F1. Comprised of shares of restricted common stock granted pursuant to the Issuer's 2018 Equity Incentive Plan that are subject to vesting.
- F2. The reported award was granted in lieu of cash compensation for the reporting person's service as a member of the Board of Directors.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ATER director Susan Lattmann report on this Form 4?
Does this ATER Form 4 involve any indirect ownership entities like trusts or LLCs?
AI-generated analysis. How Rhea-AI works. Not financial advice.